NCT07209644View on ClinicalTrials.gov

Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis

Not yet recruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

November 1, 2026

Primary Completion Date

November 1, 2027

Study Completion Date

December 1, 2027

Conditions

Systemic Sclerosis

All Listed Sponsors

lead

Assiut University

OTHER